Evidence map›Paper›PMID 36573933›Full record

ArticleCancer cytopathology2023

Small volume biopsy diagnostic yield at initial diagnosis versus recurrence/transformation of follicular lymphoma: A retrospective Cyto-Heme Interinstitutional Collaborative study.

Megan J Fitzpatrick, Vandana Sundaram, Amy Ly, Jeremy S Abramson, Ronald Balassanian, Matthew C Cheung, Stephen L Cook, Lorenzo Falchi, Annabel K Frank, Srishti Gupta and 13 more

Open access · hybridAbstract read
In one paragraph

Article in Cancer cytopathology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 10 institutions in 2 countries.

Megan J FitzpatrickDepartment of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA.ORCID 0000-0001-9336-1865
Vandana SundaramQuantitative Sciences Unit, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.
Amy LyDepartment of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Jeremy S AbramsonDepartment of Hematology/Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Ronald BalassanianDepartment of Pathology, University of California San Francisco Hospital, San Francisco, California, USA.ORCID 0000-0001-5756-9052
Matthew C CheungDivision of Hematology, Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
Stephen L CookDepartment of Laboratory Medicine, San Francisco Veterans Affairs Health Care System, San Francisco, California, USA.
Lorenzo FalchiDepartment of Hematology/Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Annabel K FrankDepartment of Hematology/Oncology, University of California San Francisco Hospital, San Francisco, California, USA.
Srishti GuptaDepartment of Pathology, University of Virginia Medical Center, Charlottesville, Virginia, USA.ORCID 0000-0002-6808-7005
Robert P HasserjianDepartment of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Oscar LinDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.ORCID 0000-0003-2089-6118
Steven R LongDepartment of Pathology, University of California San Francisco Hospital, San Francisco, California, USA.
Joshua R MenkeDepartment of Pathology, Stanford University Hospital, Stanford, California, USA.
Eric MouDivision of Hematology, Oncology, and Blood & Marrow Transplantation, The University of Iowa, Iowa City, Iowa, USA.
Daniel R ReedSection on Hematology/Oncology, Wake Forest Baptist Health Comprehensive Cancer Center, Winston-Salem, North Carolina, USA.
Roberto Ruiz-CorderoDepartment of Pathology, University of California San Francisco Hospital, San Francisco, California, USA.ORCID 0000-0002-9747-6069
Ashley K VolaricDepartment of Pathology, University of Virginia Medical Center, Charlottesville, Virginia, USA.
Linlin WangDepartment of Pathology, University of California San Francisco Hospital, San Francisco, California, USA.
Kwun Wah WenDepartment of Pathology, University of California San Francisco Hospital, San Francisco, California, USA.
Yi XieDepartment of Pathology, University of California San Francisco Hospital, San Francisco, California, USA.
Sara L ZadehDepartment of Pathology, University of Virginia Medical Center, Charlottesville, Virginia, USA.
Dita GratzingerDepartment of Pathology, Stanford University Hospital, Stanford, California, USA.
San Francisco General Hospital · USMassachusetts General Hospital · USStanford Health Care · USMemorial Sloan Kettering Cancer Center · USUniversity of Virginia Medical Center · USAtrium Health Wake Forest Baptist · USSan Francisco VA Health Care System · USStanford Medicine · USSunnybrook Health Science Centre · CAUniversity of Iowa · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Spectrum Stanford Center for clinical and Translational Research and EducationUL1TR001085 · NCATS · STANFORD UNIVERSITY · PI CULLEN, MARK RICHARD, GREENBERG, HARRY BERNARD · 2013 to 2017
$37.1M
NCATS NIH HHS UL1 TR001085NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

backgroundFew studies have evaluated diagnostic yield of small volume biopsies (SVB) for the diagnosis and management of follicular lymphoma (FL).

methodsThe authors performed a multi-institutional retrospective analysis of SVBs including fine-needle aspiration (FNA) and needle core biopsy (NCB) for initial FL diagnosis and suspected recurrence or transformation of FL. A total of 676 workups beginning with SVB were assessed for the mean number of biopsies per workup, the proportion of workups requiring multiple biopsies, and the proportion with a complete diagnosis including grade, on initial biopsy.

resultsCompared to workups performed for question transformation/recurrence, those done for initial FL diagnosis were significantly more likely to require multiple biopsies (p < .01), had a higher mean number of biopsies per workup (1.7 vs. 1.1, absolute standardized difference = 1.1), and a lower complete diagnosis rate at initial biopsy (39% vs. 56%). At initial FL diagnosis, NCB +/- FNA was associated with fewer biopsies per workup compared to FNA +/- CB (1.2 vs. 1.9), fewer workups requiring multiple biopsies (23% vs. 83%), and a higher complete diagnosis rate (71% vs. 18%). In contrast, during assessment for transformation/recurrence, NCB and FNA showed a similar mean number of biopsies per workup (1.2 vs. 1.2) and few workups required multiple biopsies (6% vs. 19%).

conclusionsSVB at initial FL diagnosis often required additional biopsies to establish a complete diagnosis. In contrast, when assessing for transformed/recurrent FL, additional biopsies were generally not obtained regardless of SVB type, suggesting that in these clinical settings SVB may be sufficient for clinical decision-making.

Indexed as

Lymphoma, FollicularBiopsy, Fine-NeedleBiopsy, Large-Core NeedleClinical Decision-MakingHumansRetrospective Studiesfine-needle aspirationfollicular lymphomaneedle core biopsysmall volume biopsy

Identifiers

PMID36573933
PMCPMC10557381
OpenAlexW4312210538

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.